Putnam Retirement Advantage 2050 Fund Class C Shares
PAENX
NASDAQ
Weiss Ratings | PAENX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Fair | |||
Reward Grade | C | |||
Risk Index | Good | |||
Risk Grade | B- | |||
Company Info | PAENX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Provider | Franklin Templeton Investments | |||
Manager/Tenure (Years) | Brett Goldstein (5), Adrian H. Chan (4), Jacqueline Kenney (0), 2 others | |||
Website | http://www.franklintempleton.com | |||
Fund Information | PAENX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Fund Name | Putnam Retirement Advantage 2050 Fund Class C Shares | |||
Category | Target-Date 2050 | |||
Sub-Category | Target Date | |||
Prospectus Objective | Asset Allocation | |||
Inception Date | Sep 01, 2020 | |||
Open/Closed To New Investors | Open | |||
Minimum Initial Investment | 0.00 | |||
Minimum Subsequent Investment | -- | |||
Front End Fee | -- | |||
Back End Fee | -- | |||
Dividends and Shares | PAENX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Yield | 3.77% | |||
Dividend | PAENX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Yield (Forward) | 1.92% | |||
Asset Allocation | PAENX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash | -2.81% | |||
Stock | 83.43% | |||
U.S. Stock | 63.75% | |||
Non-U.S. Stock | 19.68% | |||
Bond | 17.75% | |||
U.S. Bond | 15.22% | |||
Non-U.S. Bond | 2.53% | |||
Preferred | 0.11% | |||
Convertible | 0.03% | |||
Other Net | 1.49% | |||
Price History | PAENX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | 2.02% | |||
30-Day Total Return | 3.86% | |||
60-Day Total Return | 7.66% | |||
90-Day Total Return | 13.21% | |||
Year to Date Total Return | 7.95% | |||
1-Year Total Return | 12.39% | |||
2-Year Total Return | 38.41% | |||
3-Year Total Return | 58.30% | |||
5-Year Total Return | 78.74% | |||
Price | PAENX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Closing Price | -- | |||
1-Month Low Price | -- | |||
1-Month High Price | -- | |||
52-Week Low Price | -- | |||
52-Week Low Price (Date) | -- | |||
52-Week High Price | -- | |||
52-Week High Price (Date) | -- | |||
NAV | PAENX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Nav | $12.08 | |||
1-Month Low NAV | $11.64 | |||
1-Month High NAV | $12.08 | |||
52-Week Low NAV | $9.93 | |||
52-Week Low NAV (Date) | Apr 08, 2025 | |||
52-Week High NAV | $12.24 | |||
52-Week High Price (Date) | Dec 06, 2024 | |||
Beta / Standard Deviation | PAENX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 0.80 | |||
Standard Deviation | 13.15 | |||
Balance Sheet | PAENX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Total Assets | 25.13M | |||
Operating Ratios | PAENX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Expense Ratio | 1.55% | |||
Turnover Ratio | 21.00% | |||
Performance | PAENX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Last Bull Market Total Return | 15.36% | |||
Last Bear Market Total Return | -14.84% | |||